PuSH - Publikationsserver des Helmholtz Zentrums München

Bunz, M.* ; Eisele, M.* ; Hu, D.* ; Ritter, M.* ; Kammerloher, J. ; Lampl, S. ; Schindler, M.*

CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cells.

Front. Cell. Infect. Microbiol. 14:1338606 (2024)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The tetraspanin CD81 is one of the main entry receptors for Hepatitis C virus, which is a major causative agent to develop liver cirrhosis and hepatocellular carcinoma (HCC). Here, we identify CD81 as one of few surface proteins that are downregulated in HCV expressing hepatoma cells, discovering a functional role of CD81 beyond mediating HCV entry. CD81 was downregulated at the mRNA level in hepatoma cells that replicate HCV. Kinetics of HCV expression were increased in CD81-knockout cells and accompanied by enhanced cellular growth. Furthermore, loss of CD81 compensated for inhibition of pro-survival TBK1-signaling in HCV expressing cells. Analysis of functional phenotypes that could be associated with pro-survival signaling revealed that CD81 is a negative regulator of NF-κB. Interaction of the NF-κB subunits p50 and p65 was increased in cells lacking CD81. Similarly, we witnessed an overall increase in the total levels of phosphorylated and cellular p65 upon CD81-knockout in hepatoma cells. Finally, translocation of p65 in CD81-negative hepatoma cells was markedly induced upon stimulation with TNFα or PMA. Altogether, CD81 emerges as a regulator of pro-survival NF-κB signaling. Considering the important and established role of NF-κB for HCV replication and tumorigenesis, the downregulation of CD81 by HCV and the associated increase in NF-κB signaling might be relevant for viral persistence and chronic infection.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Cd81 ; Hcc ; Nf-κb ; Hepatitis C Virus ; Hepatocellular Carcinoma ; Tetraspanin; Nuclear-factor; Hepatocellular-carcinoma; Superinfection Exclusion; Protein-kinase; Surface Cd4; Core; Activation; Receptor; Liver; Interferon
ISSN (print) / ISBN 2235-2988
e-ISSN 2235-2988
Zeitschrift Frontiers in Cellular and Infection Microbiology
Quellenangaben Band: 14, Heft: , Seiten: , Artikelnummer: 1338606 Supplement: ,
Verlag Frontiers
Verlagsort Lausanne
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Virology (VIRO)
Förderungen University Hospital Tubingen, Medical Faculty
DFG German Research Foundation